Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abdullahi Ibrahim Uba & Kemal Yelekçi. (2019) Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. Journal of Biomolecular Structure and Dynamics 37:14, pages 3627-3636.
Read now
Read now
Victor Jeannot, Benoit Busser, Laetitia Vanwonterghem, Sophie Michallet, Sana Ferroudj, Murat Cokol, Jean-Luc Coll, Mehmet Ozturk & Amandine Hurbin. (2016) Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. OncoTargets and Therapy 9, pages 6843-6855.
Read now
Read now
Articles from other publishers (11)
Yawen Yang, Qingqing Liu, Xinyi Wang & Shaohua Gou. (2023) Design, Synthesis, and Biological Evaluation of Histone Deacetylase Inhibitors Derived from Erianin and Its Derivatives. ChemMedChem 18:13.
Crossref
Crossref
Xiaopeng Peng, Ling Li, Jingxuan Chen, Yichang Ren, Jin Liu, Ziwen Yu, Hao Cao & Jianjun Chen. (2022) Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma. Journal of Medicinal Chemistry 65:3, pages 2434-2457.
Crossref
Crossref
Georgia Stewart, Andrew Chantry & Michelle Lawson. (2021) The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma. Cancers 13:22, pages 5687.
Crossref
Crossref
Hong-Chieh Tsai, Kuo-Chen Wei, Pin-Yuan Chen, Chiung-Yin Huang, Ko-Ting Chen, Ya-Jui Lin, Hsiao-Wei Cheng, Yi-Rou Chen & Hsiang-Tsui Wang. (2021) Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway. Frontiers in Oncology 11.
Crossref
Crossref
Rihan Hai, Liuer He, Guang Shu & Gang Yin. (2021) Characterization of Histone Deacetylase Mechanisms in Cancer Development. Frontiers in Oncology 11.
Crossref
Crossref
Xiaopeng Peng, Jingxuan Chen, Ling Li, Zhiqiang Sun, Jin Liu, Yichang Ren, Junli Huang & Jianjun Chen. (2021) Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry 64:12, pages 8447-8473.
Crossref
Crossref
Elham Gholizadeh, Mostafa Rezaei-Tavirani, Alireza Emadi, Reza Karbalaei & Ali Khaleghian. (2021) A New Drug Discovery Approach Based on Thermal Proteome Profiling to Develop More Effective Drugs. Middle East Journal of Rehabilitation and Health Studies 8:2.
Crossref
Crossref
Ying Wu, Lei Wang, Yahui Huang, Shuqiang Chen, Shanchao Wu, Guoqiang Dong & Chunquan Sheng. (2019) Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide. ACS Medicinal Chemistry Letters 11:1, pages 40-44.
Crossref
Crossref
Yahui Huang, Guoqiang Dong, Huanqiu Li, Na Liu, Wannian Zhang & Chunquan Sheng. (2018) Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. Journal of Medicinal Chemistry 61:14, pages 6056-6074.
Crossref
Crossref
Wei Chen, Guoqiang Dong, Ying Wu, Wannian Zhang, Chaoyu Miao & Chunquan Sheng. (2017) Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery. ACS Medicinal Chemistry Letters 9:1, pages 34-38.
Crossref
Crossref
Guoqiang Dong, Wei Chen, Xia Wang, Xinglin Yang, Tianying Xu, Pei Wang, Wannian Zhang, Yu Rao, Chaoyu Miao & Chunquan Sheng. (2017) Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. Journal of Medicinal Chemistry 60:19, pages 7965-7983.
Crossref
Crossref